1. Home
  2. PRAX vs SNAP Comparison

PRAX vs SNAP Comparison

Compare PRAX & SNAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$364.58

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Logo Snap Inc.

SNAP

Snap Inc.

HOLD

Current Price

$5.23

Market Cap

7.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
SNAP
Founded
2015
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
7.7B
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
PRAX
SNAP
Price
$364.58
$5.23
Analyst Decision
Strong Buy
Hold
Analyst Count
15
26
Target Price
$572.13
$8.41
AVG Volume (30 Days)
401.0K
33.1M
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
35.71
EPS
N/A
N/A
Revenue
N/A
$824,949,000.00
Revenue This Year
N/A
$15.55
Revenue Next Year
$7,758.26
$9.82
P/E Ratio
N/A
N/A
Revenue Growth
N/A
103.95
52 Week Low
$37.25
$3.81
52 Week High
$392.45
$9.28

Technical Indicators

Market Signals
Indicator
PRAX
SNAP
Relative Strength Index (RSI) 58.43 53.54
Support Level $291.44 $4.43
Resistance Level N/A $5.76
Average True Range (ATR) 19.51 0.28
MACD 2.70 -0.00
Stochastic Oscillator 76.31 41.83

Price Performance

Historical Comparison
PRAX
SNAP

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About SNAP Snap Inc.

Snap is a technology company best known for its marquis social media application. Snapchat, a visual messaging application that has amassed hundreds of millions of users. The app was initially only used to communicate with family and friends through photographs and short videos (known as "Snaps"). Users can now enjoy augmented reality, or AR, lenses, content from famous creators and celebrities, updates about local events, and more. Although the app offers a paid subscription option with premium features, advertising sales produce most of the app's revenue. The firm also sells wearable devices called AR Spectacles, which can capture photos and videos overlayed with AR lenses, but these make up a small portion of Snap's overall sales.

Share on Social Networks: